Silvio Antoniak, PhD, assistant professor in the 黑料网 Department of Pathology and Laboratory Medicine and member of the 黑料网 Blood Research Center and the 黑料网 McAllister Heart Institute, was awarded a four-year, $2.2 million grant from the NIH-NHLBI to investigate the potential therapeutic approach in inhibiting PAR1 to treat chemotherapy-induced heart failure.